Arkolith/Insider Trading/BNTC/Form 4

Suvretta Capital Management, LLC

Director, 10% OwnerBenitec Biopharma Inc. (BNTC) · full profile →Form 4 · filed Dec 5, 2024
Net Buying
Open-Market Buys
$403K
Open-Market Sells
$0
Net Open-Market Flow
$403K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 3, 2024Buy(P)5K$9.60$46K955K
Dec 3, 2024Buy(P)37K$9.60$357K8.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899140-24-001318) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML